Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.1 at the end of 2023 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Pharmaceutical tycoon Adar Poonawalla’s Serene Productions is investing $119 million in Indian media personality Karan ...

This comes amid calls to overhaul the existing scheme, Vaccine Damage Payment Scheme (VDPS), which is being overloaded with ...

Under the new structure, Johar will retain 50% ownership ... COVID-19 pandemic for its role in manufacturing the Oxford-AstraZeneca vaccine (known as Covishield in India). Poonawalla also serves ...

“Mutational escape in SARS-CoV-2 has been a persistent challenge, with current vaccines and treatments ... of the immune system's natural defense structure that helps fight infections.

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

This article highlights several inspiring men and women working across academia and industry who are breaking barriers and ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...